Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Aggregate statistics from Disclosed's verified COA corpus. All numbers are computed directly from lab-uploaded Certificates of Analysis — no editorial claims, no estimates.
COAs
128
Labs
13
2 verified
Vendors tested
30
Avg purity
99.6%
±0.3%
Endotoxin tested
32%
of all COAs tested
Sterility tested
9%
of all COAs tested
Methodology:Purity averages exclude values outside [50%, 100%] to filter unit misreads. "Vendors tested" counts distinct vendor IDs across all in-scope, non-withdrawn, extracted COAs. Endotoxin/sterility coverage denominators are all in-scope COAs (not filtered to parenteral form).
Data updates hourly. All figures are computed from lab-uploaded COAs; Disclosed does not perform independent testing.
Based on 128 Certificates of Analysis in the Disclosed corpus, Semaglutide has an average HPLC purity of 99.6% (±0.3% std dev). This figure spans 30 vendors tested across 13 independent labs. Purity is measured by high-performance liquid chromatography (HPLC); values outside 50–100% are excluded as unit misreads.
13 distinct testing labs have produced COAs for Semaglutide in the Disclosed database, covering 128 total tests across 30 vendors. 2 of those labs have a verified Disclosed partner account, meaning their COAs are uploaded directly by the lab.
32% of Semaglutide COAs in the Disclosed corpus include endotoxin test results (USP <85>), and 9% include sterility results (USP <71>). Endotoxin and sterility testing matter for injectable-grade peptides — their absence in a COA does not indicate failure, but absence is common in HPLC-only testing workflows.
Verified labs with COAs for Semaglutide in the Disclosed corpus include: ILS Labs (grade B, 3 COAs); Ethos Analytics (grade C, 1 COA). These grades reflect Disclosed's credibility scoring of each lab's full COA corpus — purity distribution, safety panel breadth, and verification engagement.
Disclosed Labs